ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$3.07 USD
+0.25 (8.87%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.08 +0.01 (0.33%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, ADC Therapeutics (ADCT) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 13.64%. Look out for ADCT's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 39.66%.
Earnings History
Price & Consensus
Zacks News for ADCT
Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates
ADCT: What are Zacks experts saying now?
Zacks Private Portfolio Services